Examiner Sharma Santosh

1663-SHARMA-SANTOSH

Employment Information

Art Unit:1663 — Multicellular living organisms and unmodified parts thereof and related processes
Group:1660 — Asexually Reproduced Plant Varieties, Plants cultivars and transgenic plants
Classes: 800 — Multicellular living organisms and unmodified parts thereof and related processes
435 — Chemistry: molecular biology and microbiology
426 — Food or edible material: processes, compositions, and products
Phone:Available with subscription
Email:Available with subscription
Title:Pat Examnr (Biolgy)
Service:4 years
Grade:GS-11

Grant Rate and Difficulty Ranking

72
3-Year Grant rate: 59% over 41 cases
Difficulty: Harder
Difficulty Percentile: 72nd

With Examiner Sharma, you have a 59% chance of getting an issued patent by 3 years after the first office action. Examiner Sharma is a harder examiner and in the 72nd percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Sharma, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1663

Examiner Sharma's grant rate is lower than that of Art Unit 1663 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Sharma 1.8
Art Unit 1663 1.2

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...